May 19th, 2017: Aptys has been granted the GMP status by the French Agency (ANSM) for quality control of human medicinal products and human investigational medicinal products
This new status acknowledges the high quality level of Aptys. It allows to extend its historical offer, e.g. design of formulations and analytical methods, to quality control of commercial as well as clinical products.
BECOMIX laboratory homogenizing mixer type RW 30 CD
This laboratory mixing device has the same features as the production plants homogenizers.
It is used for product and process development, clinical samples, production of small quantities, and scale-up for pharmaceutical and cosmetic products, such as pharmaceutical creams and gels, cosmetic creams, tooth paste, gel products, mascara, make‐up.
We can create processes identical to those later realized on the production scale. This allows for product development under production conditions and later simplifies transfer and scaling up of the processes.
Flow Through Cell Dissolution SOTAX CE 7smart (USP-4)
In the flow-through method, the test sample is located in a small volume cell through which media is pumped at a temperature of 37 °C.
The flow through technique is able to fulfill the requirements of complex formulations such as powders, APIs, lipophilic forms e.g. suppositories, suspensions, liposomes, microspheres, semi-solids, implants and medical devices e.g. drug eluting stents.
APTYS has successfully renewed its ISO 9001 certification, click HERE to see the certificate
January 2017. Unither Pharmaceuticals and Aptys Pharmaceuticals start the development of an innovative product to treat moderate to severe pain
« We are delighted to collaborate with Aptys Pharmaceuticals, a company well-known in the field of innovative formulation development » declares Eric Goupil, President and CEO of Unither Pharmaceuticals.
« We are very pleased with this partnership with Unither Pharmaceuticals which will bring all its experience in pharmaceutical, clinical and regulatory development» adds François Boutignon, President and CEO of Aptys Pharmaceuticals.
Michel FRADIN, COO and Responsible Pharmacist and Luc BRZUSTOWSKI, CFO have joined APTYS Pharmaceuticals.
Michel holds a Doctorate in Pharmacy and a PhD in Pharmaco-Chemistry. He has 26 years of international pharmaceutical industry experience.
At MERCK SHARP & DOHME, his main positions were Head of Pharmaceutical Technical Operations Department, Responsible Pharmacist and Regional Business Operations Director (Europe Middle East Africa).
Luc is a certified Accountant and holds a Master in Business Procedural Law.
He has more than 32 years of experience in finance, including corporate finance, audit and fund raising. He worked with several Accounting firms such as KPMG and COFEXCE. In 1994, he founded his own firm.